Literature DB >> 28506906

Controlling liver cancer mortality on a global scale: Still a long way to go.

Massimo Colombo1, Patrick Maisonneuve2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28506906     DOI： 10.1016/j.jhep.2017.05.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  Lactonic sophorolipid-induced apoptosis in human HepG2 cells through the Caspase-3 pathway.

Authors:  Xiao Wang; Na Xu; Qinglin Li; Shengqi Chen; Hui Cheng; Mo Yang; Ting Jiang; Jun Chu; Xiaojing Ma; Dengke Yin
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-13       Impact factor: 4.813

2.  Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.

Authors:  Jin Yang; Yunquan Zhang; Lisha Luo; Runtang Meng; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2018-01-22       Impact factor: 3.390

3.  Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development.

Authors:  Qi Wang; Qin Tang; Lijun Zhao; Qiong Zhang; Yuxin Wu; Hui Hu; Lanlan Liu; Xiang Liu; Yanhong Zhu; Anyuan Guo; Xiangliang Yang
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

4.  Nanoliposome C6-Ceramide in combination with anti-CTLA4 antibody improves anti-tumor immunity in hepatocellular cancer.

Authors:  Xiaoqiang Qi; Feng Wu; Sung Hoon Kim; Jussuf T Kaifi; Eric T Kimchi; Helena Snyder; Anuradha Illendula; Todd Fox; Mark Kester; Kevin F Staveley-O'Carroll; Guangfu Li
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

Review 5.  Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity.

Authors:  Loraine Kay D Cabral; Claudio Tiribelli; Caecilia H C Sukowati
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.